Article
Author: Lindberg, Samsa ; Andersen, Jacob Lauwring ; García-Alai, Maria Marta ; Egebjerg, Jan ; Thirup, Søren ; Christensen, Søren ; Watson, Steven P ; Simonsen, Klaus Baek ; de Jong, Inge E M ; Malik, Ibrahim John ; Maltas, Philip James ; David, Laurent ; Eskildsen, Jørgen Calí ; Strandbygård, Dorthe ; Tagmose, Lena ; Uppalanchi, Srinivas ; Langgård, Morten ; Rønn, Lars Christian Biilmann ; Schrøder, Tenna Juul ; Sakumudi, Durga Rao ; Pallesen, Lone Tjener ; Eradi, Pradheep ; Karlsson, Jens-Jacob
Sortilin is a type I membrane glycoprotein belonging to the vacuolar protein sorting 10 protein (Vps10p) family of sorting receptors and is most abundantly expressed in the central nervous system. Sortilin has emerged as a key player in the regulation of neuronal viability and has been implicated as a possible therapeutic target in a range of disorders. Here, the identification of AF40431, the first reported small-molecule ligand of sortilin, is reported. Crystals of the sortilin–AF40431 complex were obtained by co-crystallization and the structure of the complex was solved to 2.7 Å resolution. AF40431 is bound in the neurotensin-binding site of sortilin, with the leucine moiety of AF40431 mimicking the binding mode of the C-terminal leucine of neurotensin and the 4-methylumbelliferone moiety of AF40431 forming π-stacking with a phenylalanine.